The purpose of this study is to understand if a behavioral lifestyle intervention called the Healthy Liver/Hígado Sano program can help Hispanic/Latino patients with metabolic dysfunction associated steatotic liver disease (MASLD), also known as non-alcoholic fatty liver disease (NAFLD), lose weight and improve their liver health
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
64
Participants will attend weekly classes over the 6-month period. This consists of 16 core sessions delivered in the first 6 months (weekly, but with flexibility to skip weeks as necessary due to holidays, etc). The sessions are 30-60 minutes long, conducted in a group setting, with a CDC-certified Lifestyle Coach facilitating the sessions.
participants will first complete a 30- to 45-minute questionnaire that will cover topics such as physical activity, diet, alcohol use, and stress.Participants will then be asked to wear an accelerometer for 7 days and complete a log to identify when it was worn and removed each day.Height and weight will also be measured and a Fibroscan® assessment (to measure amount of fat and scar tissue in the liver), as well as blood work to monitor the liver enzymes will be done
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Feasibility as assessed by the number of participants recruited
Recruitment will be assessed to be feasible if ≥65% of eligible participants enroll in the study
Time frame: Baseline
Number of participants that completed the study
Time frame: 6 months
Number of participants that completed the study
Time frame: 12 months
Number of participants that adhered to the protocol
Time frame: 6 months
Number of participants that adhered to the protocol
Time frame: 12 months
Participant satisfaction as assessed by the Client Satisfaction Questionnaire (CSQ-8)
The CSQ-8 is an 8-item self-report instrument assessing satisfaction with services received. Each item is rated on a 4-point Likert scale (1 = least satisfied, 4 = most satisfied). Item scores are summed to produce a total score ranging from 8 to 32, with higher scores indicating greater satisfaction.
Time frame: 6 months
Change in physical activity using the self-reported International Physical Activity Questionnaire(IPAQ)
This is a 27 item questionnaire assessing the frequency (days per week) and duration (minutes per day) of physical activities across four domains: work, transportation, household/gardening, and leisure-time, as well as time spent sitting. Physical activity scores are calculated in metabolic equivalent task minutes per week (MET-minutes/week) by multiplying activity intensity (Walking = 3.3 METs, Moderate = 4.0 METs, Vigorous = 8.0 METs) × duration × frequency within each domain. Total physical activity is obtained by summing across all domains, and respondents are classified into Low, Moderate, or High activity categories according to standardized IPAQ scoring guidelines.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline, 6 months, 12 months
Change in physical activity as assessed by the Actigraph GT9X accelerometers
Time frame: Baseline, 6 months, 12 months
Change in diet as assessed by the National Cancer Institute's Family Life, Activity, Sun, Health, and Eating (FLASHE) dietary screener self reported questionnaire
This is a 27-item questionnaire that captures past 7-day consumption of fast and junk foods, sugary foods/desserts, fruits and vegetables, and sugar-sweetened beverages. Each item is scored based on reported frequency (ranging from "Never" to "2 or more times per day"). For each food category, responses are converted to frequency per day. Higher frequencies indicate greater reported intake of that food category
Time frame: Baseline, 6 months, 12 months
Change in weight
Time frame: Baseline, 6 months, 12 months
Change in Liver steatosis (fatty liver disease) and/or stiffness assessed using the Fibroscan data
Time frame: Baseline, 6 months, 12 months
Change in liver steatosis (fatty liver disease) and/or stiffness using liver enzyme information using blood draws
Time frame: Baseline, 6 months, 12 months
Change in fasting glucose levels
Time frame: Baseline, 6 months, 12 months